- Home
- GEL vs AMLX Comparison
GEL vs AMLX Comparison
Compare GEL & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GEL | AMLX |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GEL | AMLX |
|---|---|---|
| Price | $14.20 | $18.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $19.50 | ★ $21.56 |
| AVG Volume (30 Days) | 432.0K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.19% | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,912,770,000.00 | $380,786,000.00 |
| Revenue This Year | $12.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 43.60 | ★ 1612.94 |
| 52 Week Low | $13.75 | $7.48 |
| 52 Week High | $18.64 | $19.15 |
Technical Indicators
Market Signals| Indicator | GEL | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 69.75 |
| Support Level | $13.75 | $12.17 |
| Resistance Level | $16.38 | $18.61 |
| Average True Range (ATR) | 0.53 | 1.04 |
| MACD | 0.02 | 0.33 |
| Stochastic Oscillator | 23.75 | 83.43 |
Price Performance
Historical ComparisonAbout GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.